DocuSign for Pharmaceuticals helps life sciences companies accelerate drug development by digitizing agreement processes across R&D, clinical trials, and commercialization. Automating workflows reduces manual tasks, boosts compliance, and shortens cycle times. Features like eSignature, 21 CFR Part 11 compliance, and AI-driven insights improve accuracy, cut costs, and support secure, validated documentation. From patient e-consents to KOL contracts, DocuSign enhances operational efficiency and strengthens provider relationships—helping 12 of the top 14 pharma companies get life-saving treatments to market faster.

Join for free to read